导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.46% | 466/1050 |
| 近一周 | -2.05% | 426/1104 |
| 近一月 | -4.94% | 602/1102 |
| 近一季 | -8.25% | 591/1092 |
| 近半年 | -2.36% | 486/1070 |
| 近一年 | 5.52% | 458/1018 |
| 近两年 | 46.73% | 525/926 |
| 近三年 | 31.60% | 381/834 |
| 成立以来 | 107.41% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.60% 440/1070 |
17.46% 416/1101 |
- - |
- - |
| 2025 | 20.94% 650/1065 |
2.41% 613/1014 |
0.42% 656/1038 |
17.73% 672/1050 |
-0.11% 460/1065 |
| 2024 | 15.22% 168/1011 |
3.38% 151/960 |
0.21% 293/983 |
14.82% 244/991 |
-3.14% 546/1011 |
| 2023 | -9.81% 325/952 |
2.94% 449/880 |
-0.78% 229/895 |
-4.24% 252/915 |
-7.79% 744/952 |
| 2022 | -21.18% 378/867 |
-9.08% 87/773 |
6.45% 441/806 |
-14.81% 551/845 |
-4.41% 620/867 |
| 2021 | 4.69% 306/740 |
-3.52% 283/580 |
17.36% 200/659 |
-5.05% 357/704 |
-2.64% 533/740 |
| 2020 | 51.63% 234/554 |
-3.10% 237/419 |
20.61% 276/466 |
12.80% 185/517 |
15.03% 202/554 |
| 2019 | 35.89% 256/410 |
24.32% 757/1149 |
-2.35% 542/1231 |
0.71% 317/390 |
11.14% 128/410 |
| 2018 | -25.82% 159/349 |
- - |
- - |
- - |
-12.07% 587/1080 |
| 2017 | -1.73% 181/285 |
- - |
- - |
- - |
- - |
| 2016 | 4.19% 20/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 长信量化多策略股票A VS. 东吴新产业精选股票A(580008) |